GRP
ZVRA icon

Global Retirement Partners’s Zevra Therapeutics ZVRA Stock Holding History

Global Retirement Partners’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$125 Hold
15
– – ﹤0.01% 3533
2024
Q3 		$104 Hold
15
– – ﹤0.01% 3404
2024
Q2 		$74 Hold
15
– – ﹤0.01% 3470
2024
Q1 		$87 Hold
15
– – ﹤0.01% 3306
2023
Q4 		$87 Hold
15
– – ﹤0.01% 3279
2023
Q3 		$69 Hold
15
– – ﹤0.01% 3188
2023
Q2 		$77 Hold
15
– – ﹤0.01% 3142
2023
Q1 		$75 Hold
15
– – ﹤0.01% 3138
2022
Q4 		$69 Hold
15
– – ﹤0.01% 2985
2022
Q3 		$0 Hold
15
– – ﹤0.01% 3022
2022
Q2 		$0 Hold
15
– – ﹤0.01% 2915
2022
Q1 		$0 Hold
15
– – ﹤0.01% 2811
2021
Q4 		$0 Hold
15
– – ﹤0.01% 1873
2021
Q3 		$0 Hold
15
– – ﹤0.01% 2076
2021
Q2 		$0 Hold
15
– – ﹤0.01% 1968
2021
Q1 		$0 Buy
+15
New +$131 ﹤0.01% 1918

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Global Retirement Partners's ZVRA Position: Q4 2024 in Review

Global Retirement Partners held its Zevra Therapeutics (ZVRA) position steady in Q4 2024 at 15 shares worth $125. The position accounts for ﹤0.01% of the portfolio, ranked #3533.

Global Retirement Partners first reported a position in ZVRA in Q1 2021 and has held it in 16 quarters since. 109 funds tracked by Wall St. Rank hold ZVRA as of Q4 2024.

  • Global Retirement Partners held 15 shares of Zevra Therapeutics worth $125 as of Q4 2024.
  • Global Retirement Partners left its Zevra Therapeutics share count unchanged in Q4 2024.
  • Zevra Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2024, its #3533 holding.
  • Global Retirement Partners first reported a position in Zevra Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • 109 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.